Source: Fobi.
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Fobi (FOBI) is expanding its technology solutions to the Asia-Pacific region, having launched in Japan
  • The team has identified new opportunities to explore within Japan’s tech, hospitality, and sports markets
  • Vancouver-based Fobi is an AI and data intelligence company that leverages and monetizes customer data by powering personalized customer experiences
  • Fobi AI (FOBI) opened trading at $0.44 per share

Fobi (FOBI) is expanding its technology solutions to the Asia-Pacific region, having launched in Japan.

The team has identified new opportunities to explore within Japan’s tech, hospitality, and sports markets.

The company’s VP of Marketing, Ian Cameron, explained that Japan is a country at the forefront of mobile and technological innovation, and its rapid adoption of digital wallets and non-payment functions offers a significant opportunity for Fobi overseas.

“With my experience and close connections to Japan, I am confident that we can successfully drive growth and reach new levels of global impact in this region. This launch marks a major milestone for Fobi, and we look forward to continuing to expand our footprint in APAC and beyond.”

Rob Anson, CEO of Fobi, added that expansion into the Asia-Pacific region had been part of the company’s plan for quite some time.

“The foundation of Japanese business is built on relationships, trust, and credibility, which is a great match with Ian’s strong roots and business relationships in Japan, coupled with our list of top-tier clients and use cases. Japan is one of the leading countries when it comes to mobile wallet adoption, and I am very confident that it will be the perfect launch for us into the Asia-Pacific markets.”

Vancouver-based Fobi is an AI and data intelligence company that leverages and monetizes customer data by powering personalized customer experiences.

Fobi AI (FOBI) opened trading at $0.44 per share.

More From The Market Herald
Neuralink - Founder, Elon Musk.

" Neuralink brain chips approved for human trials

Elon Musk’s Neuralink, a brain implant firm, has received regulatory approval for U.S. human trials.

" @ the Bell: TSX snaps three-day losing skid

After a series of sessions in the red, Canada’s main stock index closed out Friday trading in the green as commodity prices nudged

" Marvell stock spikes 30 per cent on Q1 news  

Marvell Technology (NASDAQ:MRVL) shares rose more than 30 per cent Friday.